New antimicrobial agents as therapy for resistant gram-positive cocci (Q36953330)

17 August 2017

1 reference

title

New antimicrobial agents as therapy for resistant gram-positive cocci (English)

1 reference

17 August 2017

gram-positive bacteria

0 references

author name string

Lentino JR

series ordinal

1

1 reference

PubMed ID

17899228

17 August 2017

Narita M

series ordinal

2

1 reference

PubMed ID

17899228

17 August 2017

Yu VL

series ordinal

3

1 reference

17 August 2017

1 January 2008

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

17 August 2017

1 reference

17 August 2017

27

1 reference

17 August 2017

1

1 reference

17 August 2017

3-15

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-007-0389-y

17 August 2017

0 references

cites work

Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

The growing menace of community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

Coagulase-negative staphylococci: pathogens associated with medical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

Linezolid: the first oxazolidinone antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0389-Y

Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

12 December 2020

Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections

1 reference

12 December 2020

Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria

1 reference

12 December 2020

Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study

1 reference

12 December 2020

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

1 reference

12 December 2020

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

1 reference

12 December 2020

Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherap

1 reference

12 December 2020

In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates

1 reference

12 December 2020

Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study

1 reference

12 December 2020

Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.

1 reference

12 December 2020

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

1 reference

12 December 2020

Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin

1 reference

12 December 2020

In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus

1 reference

12 December 2020

Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community

1 reference

12 December 2020

1 reference

12 December 2020

Linezolid in the treatment of osteomyelitis: results of compassionate use experience

1 reference

12 December 2020

Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model

1 reference

12 December 2020

In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus

1 reference

12 December 2020

Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.

1 reference

12 December 2020

Daptomycin: a cyclic lipopeptide antimicrobial agent

1 reference

12 December 2020

Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens

1 reference

12 December 2020

Vancomycin-resistant enterococci

1 reference

12 December 2020

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

12 December 2020

Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications

1 reference

12 December 2020

In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis

1 reference

12 December 2020

The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

12 December 2020

Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin

1 reference

12 December 2020

Mitochondrial toxicity associated with linezolid

1 reference

12 December 2020

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

1 reference

12 December 2020

Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model

1 reference

12 December 2020

Pathogenesis of infections due to coagulase-negative staphylococci

1 reference

12 December 2020

Recent developments in glycopeptide antibacterials

1 reference

12 December 2020

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections

1 reference

12 December 2020

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

1 reference

12 December 2020

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

1 reference

12 December 2020

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

1 reference

12 December 2020

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database

1 reference

12 December 2020

Biofilms: survival mechanisms of clinically relevant microorganisms

1 reference

12 December 2020

1 reference

12 December 2020

The glycylcyclines: a comparative review with the tetracyclines

1 reference

12 December 2020

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

1 reference

12 December 2020

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

1 reference

12 December 2020

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

1 reference

12 December 2020

Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.

1 reference

12 December 2020

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence

1 reference

12 December 2020

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

1 reference

12 December 2020

Linezolid therapy for orthopedic infections

1 reference

12 December 2020

Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis

1 reference

12 December 2020

Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis

1 reference

12 December 2020

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

12 December 2020

In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model

1 reference

12 December 2020

Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria

1 reference

12 December 2020

Linezolid induced toxic optic neuropathy

1 reference

12 December 2020

MRSA--the tip of the iceberg

1 reference

12 December 2020

Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram

1 reference

12 December 2020

Glycopeptide antibiotics: from conventional molecules to new derivatives

1 reference

12 December 2020

Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens

1 reference

12 December 2020

1 reference

12 December 2020

Hematologic effects of linezolid versus vancomycin

1 reference

12 December 2020

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

1 reference

12 December 2020

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

12 December 2020

In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods

1 reference

12 December 2020

Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy

1 reference

12 December 2020

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infect

1 reference

12 December 2020

Tigecycline: what is it, and where should it be used?

1 reference

12 December 2020

Daptomycin: a novel cyclic lipopeptide antimicrobial.

1 reference

12 December 2020

Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?

1 reference

12 December 2020

Daptomycin: a new drug class for the treatment of Gram-positive infections

1 reference

12 December 2020

Staphylococcus aureus resistant to vancomycin--United States, 2002.

1 reference

12 December 2020

Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology

1 reference

12 December 2020

Antimicrobial activity of quinupristin/dalfopristin, a new injectable streptogramin with a wide Gram-positive spectrum.

1 reference

12 December 2020

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

1 reference

12 December 2020

Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy

1 reference

12 December 2020

An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus

1 reference

12 December 2020

Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome

1 reference

12 December 2020

Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens

1 reference

12 December 2020

Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction

1 reference

12 December 2020

Alpha-Toxin Is Required for Biofilm Formation by Staphylococcus aureus

1 reference

12 December 2020

Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations

1 reference

12 December 2020

Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections

1 reference

12 December 2020

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

1 reference

12 December 2020

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

1 reference

12 December 2020

Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin

1 reference

12 December 2020

Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection

1 reference

12 December 2020

Daptomycin - a novel antibiotic against Gram-positive pathogens

1 reference

12 December 2020

Vancomycin-resistant enterococci and use of avoparcin in animal feed: is there a link?

1 reference

12 December 2020

Linezolid-associated peripheral neuropathy

1 reference

12 December 2020

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

1 reference

12 December 2020

Vancomycin-resistant enterococci: causes and control.

1 reference

12 December 2020

Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects

1 reference

12 December 2020

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial

1 reference

12 December 2020

Antimicrobial activity of tigecycline (GAR-936) against Enterococcus faecium and Staphylococcus aureus used alone and in combination

1 reference

12 December 2020

Staphylococcus aureus infections

1 reference

12 December 2020

10.1007/S10096-007-0389-Y

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17899228